However, telomere length maintenance can also be achieved in some tumour types in the absence of telomerase activity through an alternative recombination-based mechanism termed ALT (alternative lengthening of telomeres) (Bryan et al, 1995, 1997). The gene discussed is GPT; the disease is neoplasm.